Semaglutide GLP-1 Medical Weight Loss
What is Semaglutide?
Semaglutide is a compounded formulation of GLP-1, glucagon-like peptide, that was approved in 2017 under the name Ozempic® as a treatment for improving glycemic control in patients with Type 2 diabetes. It works by increasing insulin production and lowers glucagon secretion as well as targets areas in the brain that regulate appetite and food intake. Originally used for diabetes and sold under the name Ozempic®. In June 2021, Semaglutide was approved by the FDA for non-diabetic weight loss.
Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved blood sugar levels. The greatest weight loss benefits were observed when Semaglutide was used in combination with lifestyle changes, such as improved diet and consistent exercise.
GLP-1 is a hormone produced in the small intestine that stimulates insulin sensitivity and inhibits glucagon secretion, thereby lowering blood sugar. Semaglutide is a compounded Bioidentical formulation of GLP-1. It works by:
- Delaying how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.
- Slowing intestinal motility so you will feel fuller longer after meals.
- Lowering blood sugars, in part by reducing the production of sugar in the liver.
- Stimulating insulin secretion by the pancreas.
Who is not a candidate?
Patients with a history of;
- Diabetic retinopathy, a type of damage to the eye from diabetes.
- Disease of the gallbladder.
- Acute inflammation of the pancreas.
- Decreased kidney function.
- Multiple endocrine neoplasia type 2.
- Family history of medullary thyroid carcinoma.
- Patients who are insulin-dependent diabetic and those prone to diabetic ketoacidosis.
- Patients who are already on a GLP-1 medication.
A medical consultation and laboratory work by one of our experienced medical providers is required before starting the program.
- Weight loss
- Improved fertility
- Treatment of PCOS
- Smoking cessation
- Cardiovascular benefits
- Improved sleep
The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, appetite loss, and constipation. The nausea will resolve as your body adjusts to the treatment.
Medications Delivered to Your Home
To schedule your initial visit contact our office at 760-877-8747. The initial visit fee is $150 and includes medical screening by our NP in office or via telehealth (CA residents only) at your local Lab Corp office.
*The initial visit fee is non-refundable should you be ineligible for treatment or decide NOT to move forward.
After you have completed your consult, lab work, and our cleared for treatment our office will order your prescription and bill your credit card on file.
You will self administer medications weekly at home, or come in weekly to our office for injections.
Bi-Monthly in office or telehealth visits with the NP are REQUIRED to obtain a refill and will be scheduled thereafter to monitor your progress and side effects to treatment. Lab work is repeated every 3 months or sooner if needed.
Pharmacy processing and shipping takes approximately 2-4 weeks. Be sure to schedule bi-monthly follow-up visits at least 1 week before your run out of medication.
The prescription takes a week to process and ship from the pharmacy. Your prescription will ship directly to your home from the pharmacy with all supplies.
In Clinic Patients
ACCEPTING NEW PATIENTS!!!!
Once weekly Semaglutide injections in our luxurious San Marcos office for 0.25mg, 0.5mg, and 1mg doses ONLY.
4 weeks of Semaglutide $500
Patients requiring 1.7mg and 2.4mg doses will be transitioned once daily sublingual troches.
Due to supply chain issues and to ensure cost effective access to medication we are presently requiring patients needing 1.7mg and 2.4mg doses be transitioned to once daily sublingual troches,
1750 mcg 30 day supply $550
2000 mcg 30 day supply $550
A $33 shipping charge applies and medication is shipped to your home.
Your monthly fee includeds; Monthly follow-ups via telehealth or in office and any repeat labs needed.
Liraglutide – Coming Soon
Tirizepatide- Coming Soon